Back
ProShares Ultra Nasdaq Biotechnology Vs. Direxion Daily Real Estate Bull 3X ETF Industry Stock Comparison
Sell
32
BIB
ProShares Ultra Nasdaq Biotechnology
Last Price:
57.10
Seasonality Move:
16.48%
Buy
64
DRN
Direxion Daily Real Estate Bull 3X ETF
Last Price:
12.51
Seasonality Move:
11.56%
Sell
32
ProShares Ultra Nasdaq Biotechnology (BIB)
is a Sell
Is ProShares Ultra Nasdaq Biotechnology a Buy, Sell or Hold?
- The current ProShares Ultra Nasdaq Biotechnology [BIB] share price is $55.10. The Score for BIB is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
- BIB is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
64
Direxion Daily Real Estate Bull 3X ETF (DRN)
is a Buy
Is Direxion Daily Real Estate Bull 3X ETF a Buy, Sell or Hold?
- The current Direxion Daily Real Estate Bull 3X ETF [DRN] share price is $12.22. The Score for DRN is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
- DRN is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
BIB Stock Price Chart
What is ProShares Ultra Nasdaq Biotechnology's stock price today?
-
The ProShares Ultra Nasdaq Biotechnology share price today is $55.10
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BIB is experiencing buying pressure, which is a positive indicator for future bullish movement.
DRN Stock Price Chart
What is Direxion Daily Real Estate Bull 3X ETF's stock price today?
-
The Direxion Daily Real Estate Bull 3X ETF share price today is $12.22
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DRN is experiencing slight buying pressure.
BIB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.32 | Sell |
| Relative Strength Index (14 RSI): | 34.01 | Sell |
| Chaikin Money Flow: | 7453 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (57.17 - 65.17) | Sell |
| Bollinger Bands (100): | (60.25 - 66.99) | Sell |
DRN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.16 | Sell |
| Relative Strength Index (14 RSI): | 50.68 | Buy |
| Chaikin Money Flow: | 240850 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (11.71 - 12.73) | Sell |
| Bollinger Bands (100): | (10.53 - 13.09) | Buy |
BIB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 56.68 | Sell |
| 20-day SMA: | 60.68 | Sell |
| 50-day SMA: | 62.63 | Sell |
| 200-day SMA: | 59.92 | Sell |
| 8-day EMA: | 56.6 | Sell |
| 20-day EMA: | 59.52 | Sell |
| 50-day EMA: | 61.66 | Sell |
| 200-day EMA: | 60.17 | Sell |
DRN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 11.86 | Buy |
| 20-day SMA: | 12.06 | Buy |
| 50-day SMA: | 12.61 | Sell |
| 200-day SMA: | 10.26 | Buy |
| 8-day EMA: | 11.98 | Buy |
| 20-day EMA: | 12.09 | Buy |
| 50-day EMA: | 12.18 | Buy |
| 200-day EMA: | 10.85 | Buy |
ProShares Ultra Nasdaq Biotechnology Earnings Growth & BIB Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Direxion Daily Real Estate Bull 3X ETF Earnings Growth & DRN Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
ProShares Ultra Nasdaq Biotechnology Technical Analysis
| Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Direxion Daily Real Estate Bull 3X ETF Technical Analysis
| Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||